Identifying Long-term Treatment Patterns of Anti-VEGF for DME and the Ideal Dosing Paradigm
July 16th 2022While anti–vascular endothelial growth factor (VEGF) therapy is the first-line treatment for diabetic macular edema (DME), a majority of patients discontinue therapy after 6 months and there is no consensus on the ideal dosing paradigm.
Read More
Use of Local Skin Flaps May Lead to Reduced Risk of Scarring Following Mohs Surgery
July 16th 2022Three methods of cosmetic surgery—local skin flap, full thickness skin graft, and secondary intention—were evaluated for their scarring risk following Mohs microscopic surgery on the distal third of the nose.
Read More
Dr Jonathan Kentley Discusses Training Algorithms to Detect Melanoma
July 16th 2022Many algorithms claiming to identify melanoma better than dermatologists are trained on retrospective datasets, which is not reflective of real-world clinical practice, said Jonathan Kentley, MBBS, MSc, research fellow at Memorial Sloan Kettering Cancer Center.
Watch
Impact of Health Literacy on Teaching Correct Inhaler Use in COPD, Asthma
July 16th 2022A recent study found that teach-to-goal methods are more effective than brief interventions in metered-dose inhaler education for patients with chronic obstructive pulmonary disease (COPD) and asthma, but results may vary depending on levels of health literacy.
Read More
Predicting Visual Outcomes and Visual Improvement in Macular Edema Due to CRVO
July 16th 2022A machine learning model was able to predict visual outcomes and showed that the time from diagnosis to first treatment indicates visual improvement in patients with macular edema due to central retinal vein occlusion (CRVO).
Read More
Survey Finds Shift in Clinician Views of MRD Status in Treatment Decisions for Multiple Myeloma
July 16th 2022Results looking at acceptance of minimal residual disease (MRD) status found that 60% of participants “would change at least one decision based on an MRD result,” and 54% would use both MRD status and disease risk to make decisions.
Read More
Technology Allows for Earlier Detection of Eye Conditions
July 15th 2022Although technology is allowing for earlier detection of eye conditions, lack of reimbursement and insurance coverage remain major barriers to widespread use, explained speakers at the American Society of Retina Specialists 40th Annual Scientific Meeting.
Read More
Dr Paul Hahn Reviews Preferences of US vs International Retina Specialists
July 15th 2022Every year, the American Society of Retina Specialists releases the results of its latest Preferences and Trends Survey at the annual meeting. This year, the survey highlighted some surprising differences between US and international retina specialists, including off-label medication use and what drives drug choices for patients, said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.
Watch
Risk of T2D From Corticosteroid Exposure Associated With Age, Sex, BMI, Steroid Dose
July 15th 2022A recent study characterized the known association between corticosteroid exposure and type 2 diabetes (T2D), finding risk to be associated with treatment- and patient-related characteristics that can inform prescription of treatment with steroids.
Read More
House Democrats introduced a bill that would guarantee abortion access nationwide; Senator Joe Manchin, D-West Virginia, will not approve a bill that would reduce drug prices due to the energy and climate investments contained within the bill; the new Omicron subvariant of COVID-19 that is dominating the nation is more vaccine resistant.
Read More
Transformative Technology Is Driving Change in Retina Care Delivery
July 15th 2022The retina space is evolving due to new technology that is changing the way specialists deliver care, whether that means offering the ability to do new procedures in the office or providing more virtual or hybrid care.
Read More
Dr Patrick Burnett Reviews Patient Survey Findings on Unmet Needs in Psoriasis
July 14th 2022Patrick Burnett, MD, PhD, FAAD, chief medical officer of Arcutis Biotherapeutics, discusses findings of a recent survey exploring the emotional burden of plaque psoriasis and unmet needs related to current topical treatments.
Watch